R&D/Clinical Trials

>

Latest News

Understanding Chronic Inflammation Through Viral Exposure
Understanding Chronic Inflammation Through Viral Exposure

April 21st 2025

Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay uses T cell responses and cytokine levels to detect immune dysfunction and identify viral triggers of chronic inflammation.

Sanofi Advances Mid- to Late-Stage Respiratory Pipeline, Targeting Unmet Need in Asthma, COPD
Sanofi Advances Mid- to Late-Stage Respiratory Pipeline, Targeting Unmet Need in Asthma, COPD

April 21st 2025

FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion
FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion

April 18th 2025

Study: GLP-1, SGLT2s Linked to Reduced Alzheimer Disease Risk in Patients with Type 2 Diabetes
Study: GLP-1, SGLT2s Linked to Reduced Alzheimer Disease Risk in Patients with Type 2 Diabetes

April 17th 2025

New Insights Into T Cell Exhaustion and Inflammation in Long COVID
New Insights Into T Cell Exhaustion and Inflammation in Long COVID

April 17th 2025

More News